Genetic testing in inherited polyposis syndromes - how and why?

Colorectal Disease

Volumn 16, Issue 8, 2014, Pages 595-602

  Lee, G H ^a,b   Payne, S J ^a   Melville, A ^a   Clark, S K ^a,b  

^a ST MARK S HOSPITAL   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Genetic testing; Management; Polyposis syndromes

Indexed keywords

DNA GLYCOSYLASE MUTY;

ARTICLE; CONFIDENTIALITY; DNA SEQUENCE; FAMILIAL COLON POLYPOSIS; FAMILY PLANNING; FINANCIAL MANAGEMENT; GENETIC COUNSELING; GENETIC SCREENING; GERMLINE MUTATION; HEALTH CARE PERSONNEL; HUMAN; JUVENILE; MOSAICISM; PEUTZ JEGHERS SYNDROME; PRIORITY JOURNAL; SYNDROME; GASTROINTESTINAL POLYPOSIS; GENETIC PREDISPOSITION; GENETICS; MUTATION; PROCEDURES;

GENETIC PREDISPOSITION TO DISEASE; GENETIC TESTING; HUMANS; INTESTINAL POLYPOSIS; MUTATION; SYNDROME;

EID: 84904392150     PISSN: 14628910     EISSN: 14631318     Source Type: Journal    
DOI: 10.1111/codi.12600     Document Type: Article

References (56)

1. Groden J, Thliveris A, Samowitz W et al. Identification and characterization of the familial adenomatous polyposis coli gene. Cell 1991; 66: 589-600.
2. Kinzler KW, Nilbert MC, Su LK et al. Identification of FAP locus genes from chromosome 5q21. Science 1991; 253: 661-5.
3. Nishisho I, Nakamura Y, Miyoshi Y et al. Mutations of chromosome 5q21 genes in FAP and colorectal cancer patients. Science 1991; 253: 665-9.
4. Bussey HJR. (1975). Familial Polyposis Coli: Family Studies, Histopathology, Differential Diagnosis, and Results of Treatment. Johns Hopkins University Press, Baltimore, MD.
5. Nugent KP, Spigelman AD, Phillips RK. Life expectancy after colectomy and ileorectal anastomosis for familial adenomatous polyposis. Dis Colon Rectum 1993; 36: 1059-62.
6. Bisgaard ML, Fenger K, Bulow S, Niebuhr E, Mohr J. Familial adenomatous polyposis (FAP): frequency, penetrance, and mutation rate. Hum Mutat 1994; 3: 121-5.
7. Barrow P, Khan M, Lalloo F, Evans DG, Hill J. Systematic review of the impact of registration and screening on colorectal cancer incidence and mortality in familial adenomatous polyposis and Lynch syndrome. Br J Surg 2013; 100: 1719-31.
8. Hernegger GS, Moore HG, Guillem JG. Attenuated familial adenomatous polyposis: an evolving and poorly understood entity. Dis Colon Rectum 2002; 45: 127-34.
9. Nielsen M, Hes FJ, Nagengast FM et al. Germline mutations in APC and MUTYH are responsible for the majority of families with attenuated familial adenomatous polyposis. Clin Genet 2007; 71: 427-33.
10. Knudsen AL, Bisgaard ML, Bulow S. Attenuated familial adenomatous polyposis (AFAP). A review of the literature. Fam Cancer 2003; 2: 43-55.
11. Aretz S, Uhlhaas S, Goergens H et al. MUTYH-associated polyposis: 70 of 71 patients with biallelic mutations present with an attenuated or atypical phenotype. Int J Cancer 2006; 119: 807-14.
12. Nielsen M, Franken PF, Reinards TH et al. Multiplicity in polyp count and extracolonic manifestations in 40 Dutch patients with MYH associated polyposis coli (MAP). J Med Genet 2005; 42: e54.
13. Kanter-Smoler G, Bjork J, Fritzell K et al. Novel findings in Swedish patients with MYH-associated polyposis: mutation detection and clinical characterization. Clin Gastroenterol Hepatol 2006; 4: 499-506.
14. Cleary SP, Cotterchio M, Jenkins MA et al. Germline MutY human homologue mutations and colorectal cancer: a multisite case-control study. Gastroenterology 2009; 136: 1251-60.
15. Jones N, Vogt S, Nielsen M et al. Increased colorectal cancer incidence in obligate carriers of heterozygous mutations in MUTYH. Gastroenterology 2009; 137: 489-94, 94 e1; quiz 725-6.
16. Giardiello FM, Trimbath JD. Peutz-Jeghers syndrome and management recommendations. Clin Gastroenterol Hepatol 2006; 4: 408-15.
17. Aaltonen LA. Hereditary intestinal cancer. Semin Cancer Biol 2000; 10: 289-98.
18. Aretz S, Stienen D, Uhlhaas S et al. High proportion of large genomic STK11 deletions in Peutz-Jeghers syndrome. Hum Mutat 2005; 26: 513-9.
19. Beggs AD, Latchford AR, Vasen HF et al. Peutz-Jeghers syndrome: a systematic review and recommendations for management. Gut 2010; 59: 975-86.
20. Dajani YF, Kamal MF. Colorectal juvenile polyps: an epidemiological and histopathological study of 144 cases in Jordanians. Histopathology 1984; 8: 765-79.
21. Brosens LA, van Hattem A, Hylind LM et al. Risk of colorectal cancer in juvenile polyposis. Gut 2007; 56: 965-7.
22. Howe JR, Mitros FA, Summers RW. The risk of gastrointestinal carcinoma in familial juvenile polyposis. Ann Surg Oncol 1998; 5: 751-6.
23. Jass JR, Williams CB, Bussey HJ, Morson BC. Juvenile polyposis - a precancerous condition. Histopathology 1988; 13: 619-30.
24. Sieber OM, Lamlum H, Crabtree MD et al. Whole-gene APC deletions cause classical familial adenomatous polyposis, but not attenuated polyposis or 'multiple' colorectal adenomas. Proc Natl Acad Sci USA 2002; 99: 2954-8.
25. Aretz S, Uhlhaas S, Caspari R et al. Frequency and parental origin of de novo APC mutations in familial adenomatous polyposis. Eur J Hum Genet 2004; 12: 52-8.
26. Vasen HF, Moslein G, Alonso A et al. Guidelines for the clinical management of familial adenomatous polyposis (FAP). Gut 2008; 57: 704-13.
27. Al-Tassan N, Chmiel NH, Maynard J et al. Inherited variants of MYH associated with somatic G:C→T: a mutations in colorectal tumors. Nat Genet 2002; 30: 227-32.
28. Hemminki A, Markie D, Tomlinson I et al. A serine/threonine kinase gene defective in Peutz-Jeghers syndrome. Nature 1998; 391: 184-7.
29. Jenne DE, Reimann H, Nezu J et al. Peutz-Jeghers syndrome is caused by mutations in a novel serine threonine kinase. Nat Genet 1998; 18: 38-43.
30. Woodford-Richens K, Bevan S, Churchman M et al. Analysis of genetic and phenotypic heterogeneity in juvenile polyposis. Gut 2000; 46: 656-60.
31. Calva-Cerqueira D, Chinnathambi S, Pechman B, Bair J, Larsen-Haidle J, Howe JR. The rate of germline mutations and large deletions of SMAD4 and BMPR1A in juvenile polyposis. Clin Genet 2009; 75: 79-85.
32. O'Malley M, Laguardia L, Kalady MF et al. The prevalence of hereditary hemorrhagic telangiectasia in juvenile polyposis syndrome. Dis Colon Rectum 2012; 55: 886-92.
33. Lynch HT, Snyder C, Davies JM et al. FAP, gastric cancer, and genetic counseling featuring children and young adults: a family study and review. Fam Cancer 2010; 9: 581-8.
34. Duncan RE, Gillam L, Savulescu J, Williamson R, Rogers JG, Delatycki MB. The challenge of developmentally appropriate care: predictive genetic testing in young people for familial adenomatous polyposis. Fam Cancer 2010; 9: 27-35.
35. Woo A, Sadana A, Mauger DT, Baker MJ, Berk T, McGarrity TJ. Psychosocial impact of Peutz-Jeghers syndrome. Fam Cancer 2009; 8: 59-65.
36. UK Genetic Testing Network 2013. Available from http://ukgtn.nhs.uk.
37. Moulton G. Surgeons have critical role in genetic testing decisions, medical, legal experts say. J Natl Cancer Inst 1998; 90: 804-5.
38. Genetic conditions and insurance. What you need to know and what you need to tell. In: (ed. UK GA). UK: Genetic Alliance UK; 2013. Available from http://www.geneticalliance.org.uk/insurance.htm.
39. CG131 Colorectal Cancer: Costing Report. National Institute for Health and Care Excellence, London, November 2011.
40. Gayther SA, Wells D, SenGupta SB et al. Regionally clustered APC mutations are associated with a severe phenotype and occur at a high frequency in new mutation cases of adenomatous polyposis coli. Hum Mol Genet 1994; 3: 53-6.
41. Friedl W, Aretz S. Familial adenomatous polyposis: experience from a study of 1164 unrelated German polyposis patients. Hered Cancer Clin Pract 2005; 3: 95-114.
42. Nieuwenhuis MH, Vasen HF. Correlations between mutation site in APC and phenotype of familial adenomatous polyposis (FAP): a review of the literature. Crit Rev Oncol Hematol 2007; 61: 153-61.
43. Sinha A, Tekkis PP, Rashid S, Phillips RK, Clark SK. Risk factors for secondary proctectomy in patients with familial adenomatous polyposis. Br J Surg 2010; 97: 1710-5.
44. Caspari R, Olschwang S, Friedl W et al. Familial adenomatous polyposis: desmoid tumours and lack of ophthalmic lesions (CHRPE) associated with APC mutations beyond codon 1444. Hum Mol Genet 1995; 4: 337-40.
45. Davies DR, Armstrong JG, Thakker N et al. Severe Gardner syndrome in families with mutations restricted to a specific region of the APC gene. Am J Hum Genet 1995; 57: 1151-8.
46. Sinha A, Tekkis PP, Gibbons DC, Phillips RK, Clark SK. Risk factors predicting desmoid occurrence in patients with familial adenomatous polyposis: a meta-analysis. Colorectal Dis 2011; 13: 1222-9.
47. Weingarten TN, Hanson JW, Anusionwu KO et al. Management of patients with hereditary hemorrhagic telangiectasia undergoing general anesthesia: a cohort from a single academic center's experience. J Anesth 2013; 27: 705-11.
48. Dover K, Payne SJ, Bourdon L et al. RNA studies in familial adenomatous polyposis. British Human Genetics Conference, 17 September 2012, Warwick University. J Med Genet 2012; 49: S50.
49. Kadiyska TK, Todorov TP, Bichev SN et al. APC promoter 1B deletion in familial polyposis - implications for mutation negative families. Clin Genet 2013; doi: 10.1111/cge.12210 [Epub ahead of print].
50. Hes FJ, Nielsen M, Bik EC et al. Somatic APC mosaicism: an underestimated cause of polyposis coli. Gut 2008; 57: 71-6.
51. Aretz S, Stienen D, Friedrichs N et al. Somatic APC mosaicism: a frequent cause of familial adenomatous polyposis (FAP). Hum Mutat 2007; 28: 985-92.
52. Sieber OM, Lipton L, Crabtree M et al. Multiple colorectal adenomas, classic adenomatous polyposis, and germ-line mutations in MYH. N Engl J Med 2003; 348: 791-9.
53. Sampson JR, Dolwani S, Jones S et al. Autosomal recessive colorectal adenomatous polyposis due to inherited mutations of MYH. Lancet 2003; 362: 39-41.
54. Khawaja F, Payne SJ. The E447X MYH mutation is a major contributor to inherited colorectal cancer in the Gujurati population. J Med Genet 2007; 44(Suppl 1): S100.
55. Palles C, Cazier JB, Howarth KM et al. Germline mutations affecting the proofreading domains of POLE and POLD1 predispose to colorectal adenomas and carcinomas. Nat Genet 2013; 45: 136-44.
56. Ong FS, Lin JC, Das K, Grosu DS, Fan JB. Translational utility of next-generation sequencing. Genomics 2013; 102: 137-9.